兽医注射器材市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球兽医注射设备市场价值为 9.31 亿美元，预计将以 4.9% 的复合年增长率成长，到 2034 年达到 15 亿美元。

随着越来越多的家庭收养宠物并将其视为家庭成员，兽医就诊和预防保健支出大幅增加，从而推动了对用于疫苗接种、治疗和疗法的高效、安全的注射装置的需求。

注射器使用率不断上升

2024年，注射器市场占据了显着的份额，这得益于其广泛应用于伴侣动物和家畜的药物、疫苗和营养给药。这些设备因其精准度高、操作简便以及与各种针头规格和容量的兼容性而备受推崇。由于感染控制仍然是行业重点，兽用预消毒和安全增强型注射器的产量正在增加。

塑胶材质将获得青睐

塑胶材料凭藉其成本效益、轻质特性和设计灵活性，在2024年占据了相当大的市场份额。从一次性注射器到多剂量注射器，塑胶兼具耐用性和安全性。市场成长的驱动力在于大批量生产需求以及对支持诊所和农场环境卫生规范的一次性设备日益增长的需求。製造商也在探索环保生物塑胶和可回收聚合物，以应对日益增长的环境问题并符合永续发展目标。

疫苗接种和预防保健需求不断增长

2024年，随着宠物和牲畜疾病预防意识的不断增强，疫苗接种和预防保健领域创造了可观的收入。兽医和动物健康计画优先考虑注射疫苗，因为它们起效快、疗效高，尤其适用于狂犬病、口蹄疫和细小病毒等疾病。快速、精准、减少动物压力的注射装置需求旺盛，尤其是在大规模疫苗接种活动中。

区域洞察

北美将成为推动力地区

2024年，北美兽医注射器械市场占据了相当大的份额，这得益于先进的兽医医疗保健体系、较高的宠物拥有率以及完善的牲畜管理实践。动物保健投资的增加、预防性护理方案的广泛采用以及良好的监管环境，都为市场成长提供了支撑。关键参与者的参与和持续的研发投入也巩固了该地区的主导地位，尤其註重精密器械和数位追踪系统，以确保剂量的准确性。

兽医注射设备市场的主要参与者有 Neogen Corporation、Terumo Medical Corporation、Hamilton Company、Serumwerk Bernburg、Allflex USA、Medtronic plc、Zoetis、Henke-Sass、Wolf、Baxter International、NuGen Medical Devices、B. Braun Melsungen、Merck & Co. 和 Micrel Medical Devices。

为了巩固市场地位，兽用注射器材领域的领先公司正专注于创新、地理扩张和策略合作。产品开发以人体工学设计、无针注射器和自动给药系统为中心，以减少人为失误和动物压力。许多公司正在透过建立本地製造和分销合作伙伴关係来拓展新兴市场，以降低成本并扩大覆盖范围。

目录

第一章：方法论与范围

第 2 章：执行摘要

第三章：行业洞察

• 产业生态系统分析
  • 供应商格局
  • 每个阶段的增值
  • 影响价值链的因素
• 产业衝击力
  • 成长动力
    • 宠物数量的增加和伴侣动物的人性化
    • 不断增长的动物保健支出和大型动物生产需求
    • 人畜共通传染病控制计画的普及率不断上升
    • 增加新兴市场的兽医基础设施和服务可近性
  • 产业陷阱与挑战
    • 先进设备和治疗费用高昂
    • 针刺伤和交叉污染的风险
  • 市场机会
    • 预充式註射器和自动注射器在兽医护理中的应用日益增多
    • 宠物保险和宠物主人消费意愿的提高
• 成长潜力分析
• 监管格局
• 技术格局
  • 当前的技术趋势
  • 新兴技术
• 未来市场趋势
• 定价分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 全球的
  • 北美洲
  • 欧洲
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係与协作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 注射器
• 针头
• 远端注射设备
  • 桿式註射器
  • 飞镖
• 无针注射器系统
  • 弹簧式
  • 电池供电
  • 气动喷射器
• 自动注射器
• 其他注射装置

第六章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 塑胶
• 金属
• 玻璃
• 其他材料

第七章：市场估计与预测：按临床应用，2021 - 2034

• 主要趋势
• 疫苗接种及预防保健
• 抗感染药物
• 麻醉和镇痛
• 生育力和生殖
• 其他临床应用

第 8 章：市场估计与预测：按用途，2021 年至 2034 年

• 主要趋势
• 免洗设备
• 可重复使用的设备

第九章：市场估计与预测：按动物类型，2021 - 2034 年

• 主要趋势
• 伴侣动物
• 牲畜
• 其他动物

第 10 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 兽医院
• 兽医诊所
• 学术和研究机构
• 其他最终用途

第 11 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十二章：公司简介

• Allflex USA
• Baxter International
• B. Braun Melsungen
• Hamilton Company
• Henke-Sass, Wolf
• Merck & Co.
• Medtronic plc
• Micrel Medical Devices
• Neogen Corporation
• NuGen Medical Devices
• Serumwerk Bernburg
• Terumo Medical Corporation
• Zoetis

The Global Veterinary Injectable Devices Market was valued at USD 931 million in 2024 and is estimated to grow at a CAGR of 4.9% to reach USD 1.5 billion by 2034.

With more households adopting pets and treating them as family members, there is a significant rise in veterinary visits and preventive care spending-boosting demand for efficient, safe injectable devices for vaccinations, treatments, and therapies.

Rising adoption of Syringes

The syringes segment held a notable share in 2024, driven by its wide applicability in administering medications, vaccines, and nutrients to both companion and livestock animals. These devices are valued for their precision, ease of use, and compatibility with a range of needle gauges and volumes. As infection control remains a priority, the industry is witnessing increased production of pre-sterilized and safety-enhanced syringes tailored for veterinary use.

Plastic Material to Gain Traction

The plastic materials generated a significant share in 2024 owing to their cost-effectiveness, lightweight nature, and flexibility in design. From disposable syringes to multi-dose injectors, plastic offers a balance of durability and safety. The market growth is driven by high-volume production needs and the rising demand for single-use devices that support hygienic practices in both clinics and farm environments. Manufacturers are also exploring eco-friendly bioplastics and recyclable polymers to address growing environmental concerns and align with sustainability goals.

Rising Demand for Vaccination and Preventive Care

The vaccination and preventive care segment generated significant revenues in 2024, fueled by increasing awareness of disease prevention in both pets and livestock. Veterinarians and animal health programs are prioritizing injectable vaccines for their fast action and high efficacy, especially for diseases like rabies, foot-and-mouth, and parvovirus. Injectable devices designed for speed, accuracy, and reduced stress on animals are in high demand, particularly in large-scale vaccination drives.

Regional Insights

North America to Emerge as a Propelling Region

North America veterinary injectable devices market held a substantial share in 2024, backed by advanced veterinary healthcare systems, high pet ownership rates, and strong livestock management practices. Growth is supported by increased investments in animal wellness, widespread adoption of preventive care protocols, and a favorable regulatory environment. The presence of key players and ongoing R&D efforts also contributes to the region's dominance, with a focus on precision devices and digital tracking systems for dosage accuracy.

Major players involved in the veterinary injectable devices market are Neogen Corporation, Terumo Medical Corporation, Hamilton Company, Serumwerk Bernburg, Allflex USA, Medtronic plc, Zoetis, Henke-Sass, Wolf, Baxter International, NuGen Medical Devices, B. Braun Melsungen, Merck & Co., Micrel Medical Devices.

To strengthen their market position, leading companies in the veterinary injectable devices space are focusing on innovation, geographic expansion, and strategic collaborations. Product development is centered around ergonomic designs, needle-free injectors, and automated dosing systems to reduce human error and animal stress. Many players are expanding into emerging markets by setting up local manufacturing and distribution partnerships to lower costs and improve reach.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Material trends
  • 2.2.4 Clinical applications trends
  • 2.2.5 Usage trends
  • 2.2.6 Animal type trends
  • 2.2.7 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factors affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet population and humanization of companion animals
    • 3.2.1.2 Growing animal health spending and large animal production needs
    • 3.2.1.3 Rising prevalence of zoonotic and infectious disease control programs
    • 3.2.1.4 Increasing veterinary infrastructure and service access in emerging markets
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced devices and treatment
    • 3.2.2.2 Risk of needle-stick injuries and cross-contamination
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rising adoption of prefilled syringes and autoinjectors in veterinary care
    • 3.2.3.2 Rising pet insurance and willingness to spend by pet owners
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Pricing analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Syringes
• 5.3 Needles
• 5.4 Remote injectable devices
  • 5.4.1 Pole syringes
  • 5.4.2 Darts
• 5.5 Needle free injector systems
  • 5.5.1 Spring-loaded
  • 5.5.2 Battery-powered
  • 5.5.3 Gas powered jet injector
• 5.6 Auto-injectors
• 5.7 Other injectable devices

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Plastic
• 6.3 Metal
• 6.4 Glass
• 6.5 Other materials

Chapter 7 Market Estimates and Forecast, By Clinical Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Vaccination and preventive care
• 7.3 Anti-infectives
• 7.4 Anesthesia and analgesia
• 7.5 Fertility and reproduction
• 7.6 Other clinical applications

Chapter 8 Market Estimates and Forecast, By Usage, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Disposable devices
• 8.3 Reusable devices

Chapter 9 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Companion animals
• 9.3 Livestock animals
• 9.4 Other animals

Chapter 10 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 Veterinary hospitals
• 10.3 Veterinary clinics
• 10.4 Academic and research institutes
• 10.5 Other end use

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Spain
  • 11.3.5 Italy
  • 11.3.6 Netherlands
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 Australia
  • 11.4.5 South Korea
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
• 11.6 Middle East and Africa
  • 11.6.1 South Africa
  • 11.6.2 Saudi Arabia
  • 11.6.3 UAE

Chapter 12 Company Profiles

• 12.1 Allflex USA
• 12.2 Baxter International
• 12.3 B. Braun Melsungen
• 12.4 Hamilton Company
• 12.5 Henke-Sass, Wolf
• 12.6 Merck & Co.
• 12.7 Medtronic plc
• 12.8 Micrel Medical Devices
• 12.9 Neogen Corporation
• 12.10 NuGen Medical Devices
• 12.11 Serumwerk Bernburg
• 12.12 Terumo Medical Corporation
• 12.13 Zoetis